Guided Therapeutics (GTHP) Asset Writedowns and Impairment (2016 - 2025)
Guided Therapeutics recorded quarterly Asset Writedowns and Impairment of $3000.0 in Q4 2025, up 50.0% quarter-over-quarter from $2000.0 in Q3 2025, and up 400.0% year-over-year from $600.0 in Q4 2024.
Guided Therapeutics' Asset Writedowns and Impairment history runs 6 years deep, the most recent figure standing at $3000.0 for Q4 2025.
- In Q4 2025, Asset Writedowns and Impairment rose 400.0% year-over-year to $3000.0; the TTM figure through Dec 2025 stood at $4000.0 (up 300.0% YoY), while the FY2025 annual figure was $6000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment came in at $3000.0 for Q4 2025 at Guided Therapeutics, up from $2000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $3000.0 in Q4 2025 to a low of -$1000.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Mar 31, 2018 | 1,000.00 |
| Dec 31, 2017 | -124,000.00 |
| Dec 31, 2017 | -124,000.00 |
| Sep 30, 2017 | 333,000.00 |
| Sep 30, 2017 | 333,000.00 |
| Mar 31, 2017 | -35,000.00 |
| Mar 31, 2017 | -35,000.00 |
| Dec 31, 2016 | 217,000.00 |
| Dec 31, 2016 | 217,000.00 |
| Sep 30, 2016 | -16,000.00 |
| Sep 30, 2016 | -16,000.00 |